Cite
HARVARD Citation
Zer, A. et al. (2016). Original Articles: Translational Oncology - Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of thoracic oncology. 11 (3), p. . [Online].